| Description |
1 online resource |
| Contents |
Preface; Contents; Part I: New Concepts on Epidemiology and Mechanisms of Heart Failure; Chapter 1: Prevalence, Incidence and Lifetime Risk of Heart Failure; Lifetime Risk; Prevalence of Heart Failure; Asymptomatic Left Ventricular Dysfunction; Heart Failure with Reduced Versus Preserved Ejection Fraction; Incidence of Heart Failure; References; Chapter 2: Evolving Concepts on the Basic Mechanisms of Heart Failure; The Current Heart Failure Mechanisms in Heart Failure with Reduced Ejection Fraction (HFrEF); The Pump Failure; The Role of Neurohormones; The Kidney: Responsible for HF |
|
Loss of Cardiac Myocytes Dysfunctional Cardiac Myocytes due to Abnormal Cytoplasmic Ca2+ Homeostasis; The Myocardial Extracellular Matrix; Genes Contribution; Heart Failure with Preserved Ejection Fraction (HFpEF); From Left to Right Heart Failure; Noncardiac Comorbidities and HF; References; Part II: The Role of Cardiac Imaging in the Evaluation of Heart Failure; Chapter 3: Assessment of Left Ventricular Systolic and Diastolic Function by Echocardiography; Introduction; Assessment of Left Ventricular Systolic Function; Left Ventricular Fractional Shortening |
|
Left Ventricular Ejection Fraction 2D Echocardiography; 3D Echocardiography; Data Acquisition; Analysis; Stroke Volume and Cardiac Output; LV Regional Function; Doppler Methods of LV Systolic Function Evaluation; Rate of LV Pressure Increase; Myocardial Deformation Imaging; Assessment of Left Ventricular Diastolic Function; Echocardiographic Diagnosis of LVDD in Patients with HFpEF; Echocardiographic Assessment of Left Ventricular Filling Pressures and Diastolic Dysfunction Grade; References; Chapter 4: The Imaging of Right Ventricular Dysfunction in Heart Failure; Introduction |
|
Echocardiography Standard Echocardiographic Views of the RV; Right Ventricular Global Systolic Function; Conventional 2DE Parameters; 3DE Assessment of the RV Systolic Function; Right Ventricular Regional Systolic Function; RV Diastolic Function; Right Ventricular Mechanics; RV Dyssynchrony; Cardiac Magnetic Resonance; RV Global Systolic Function; RV Regional Systolic Function; RV Myocardial Mechanics; Computed Tomography; Nuclear Imaging; Conclusions; References; Chapter 5: The Role of Atrial Functional Assessment in Heart Failure; Left Atrial Function |
|
Echocardiographic Assessment of Left Atrial Function Left Atrial Function and Heart Failure; Conclusion; References; Chapter 6: Assessment of Secondary Mitral Regurgitation; Introduction; Definition, Mechanisms, and Physiopathology; Echocardiographic Assessment of SMR; Diagnosis and Mechanism of SMR; Valve Morphology: Overall Assessment; Valve Morphology: Quantitative Analysis of Mitral Valve Deformation; LV Remodeling Assessment; Quantification of SMR Severity; 2D Echocardiography; 3D Echocardiography; The Dynamic Nature of Chronic Ischaemic MR: Role of Stress Echocardiography |
| Summary |
This book is intended to be a link between guidelines and clinical practice, a complementary tool to help physicians to be well informed regarding the important field of heart failure. It will be a useful tool for professionals from all the fields of cardiology: non-invasive cardiology, interventional cardiology, electrophysiology and cardiovascular imaging. The topic of heart failure is continuously changing, with new important information being added constantly. The pathophysiology is better understood and there is a trend for a better characterization of special groups of population, such as oncologic patients with heart failure. The new imaging techniques have become valuable tools for the diagnosis of heart failure, while pharmacological and novel cell and gene treatments have evolved enormously. The challenge for the practitioners is making the right selection of treatment strategy that best fits a patient. This book presents detailed information on the indications, selection and mechanism of action of these treatments, whether they be mechanical circulatory devices or pharmacological treatments. The contemporary pharmacological and non-pharmacological management of heart failure has the main target of early prevention of disease progression and the avoidance of heart transplant. In the era of shortage of donors, prevention is the mainstay of the therapeutic strategy, and this is the main philosophy of our book |
| Notes |
Includes index |
| Bibliography |
Includes bibliographical references and index |
| In |
Springer eBooks |
| Subject |
Heart failure -- Diagnosis
|
|
Heart failure -- Treatment
|
|
Heart Failure -- diagnosis
|
|
Heart Failure -- therapy
|
|
medicines (material)
|
|
Renal medicine & nephrology.
|
|
Cardiothoracic surgery.
|
|
Anaesthetics.
|
|
Cardiovascular medicine.
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Heart failure -- Diagnosis
|
|
Heart failure -- Treatment
|
| Genre/Form |
Electronic books
|
| Form |
Electronic book
|
| Author |
Dorobanţu, Maria
|
|
Ruschitzka, Frank
|
|
Metra, Marco
|
| ISBN |
9783319452371 |
|
3319452371 |
|
